Literature DB >> 11368445

Incidence of hematological malignancies in Martinique, French West Indies, overrepresentation of multiple myeloma and adult T cell leukemia/lymphoma.

C Besson1, C Gonin, A Brebion, C Delaunay, G Panelatti, Y Plumelle.   

Abstract

A registry of hematological malignancies is held in the unit of cytology of the University Hospital of Martinique. Human T cell lymphotropic virus type-1 (HTLV1) is endemic in this island. We determined the incidence and epidemiological features of hematological malignancies from the 715 new cases diagnosed between 1990 and 1998 among the adult population. Incidence rates per year were steady during this period. The most frequent hematological malignancies were multiple myeloma (MM) (34%), followed by non-Hodgkin's lymphoma (NHL) (23%). Among the cases of NHL with an immunohistological study, 57% had a T cell phenotype. Among these 61% were adult T cell leukemia/lymphoma. Epidemiological data on hematological malignancies in the West Indies has not been previously reported. There are two striking differences with other population-based registries: a high incidence of MM (5/100000) and a high proportion of T cell NHL among NHL (57%). The high proportion of T cell NHL is probably due to the high incidence of ATL. A low incidence of B cell NHL might also contribute to this effect. The increased incidence of MM in West Indies had not been previously reported. A similar high incidence of MM has been reported among Afro-Americans in the USA.

Entities:  

Mesh:

Year:  2001        PMID: 11368445     DOI: 10.1038/sj.leu.2402040

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  8 in total

Review 1.  Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites.

Authors:  A J Greenberg; C M Vachon; S V Rajkumar
Journal:  Leukemia       Date:  2011-12-23       Impact factor: 11.528

2.  Hematological malignancies in Al-amal oncology unit, aden.

Authors:  Waiel Al-Kahiry
Journal:  Indian J Hematol Blood Transfus       Date:  2011-08-18       Impact factor: 0.900

3.  Hematological malignancies diagnosed by bone marrow examination in a tertiary hospital at Uttarakhand, India.

Authors:  Anuradha Kusum; Gita Negi; Dushyant Singh Gaur; Sanjeev Kishore; Harsh Meena; Anita Sharma; S K Verma
Journal:  Indian J Hematol Blood Transfus       Date:  2008-05-01       Impact factor: 0.900

4.  Epidemiological Aspects and World Distribution of HTLV-1 Infection.

Authors:  Antoine Gessain; Olivier Cassar
Journal:  Front Microbiol       Date:  2012-11-15       Impact factor: 5.640

5.  The epidemiological features of lymphoid malignancies in Benin City, Nigeria: a 15 years study.

Authors:  Caroline Edijana Omoti; Alexander Ikenna Nwannadi; Jude Chike Obieche; Adesuwa Noma Olu-Eddo
Journal:  Pan Afr Med J       Date:  2012-01-20

6.  Multiple metachronous malignancies, one patient with three primary malignancies: a case report.

Authors:  Horace Fletcher; Gilian Wharfe; Elaine Williams; Barrie Hanchard; Derek Mitchell
Journal:  J Med Case Rep       Date:  2007-05-02

7.  Variable risk of second primary malignancy in multiple myeloma patients of different ethnic subgroups.

Authors:  S Ailawadhi; A Swaika; P Razavi; D Yang; A Chanan-Khan
Journal:  Blood Cancer J       Date:  2014-09-05       Impact factor: 11.037

8.  Germline ATG2B/GSKIP-containing 14q32 duplication predisposes to early clonal hematopoiesis leading to myeloid neoplasms.

Authors:  Jean Pegliasco; Pierre Hirsch; Christophe Marzac; Françoise Isnard; Jean-Côme Meniane; Caroline Deswarte; Philippe Pellet; Céline Lemaitre; Gwendoline Leroy; Graciela Rabadan Moraes; Hélène Guermouche; Barbara Schmaltz-Panneau; Florence Pasquier; Chrystelle Colas; Patrick R Benusiglio; Odile Bera; Jean-Henri Bourhis; Eolia Brissot; Olivier Caron; Samy Chraibi; Pascale Cony-Makhoul; Christine Delaunay-Darivon; Simona Lapusan; Flore Sicre de Fontbrune; Pascal Fuseau; Albert Najman; William Vainchenker; François Delhommeau; Jean-Baptiste Micol; Isabelle Plo; Christine Bellanné-Chantelot
Journal:  Leukemia       Date:  2021-06-25       Impact factor: 11.528

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.